Germany and the UK are in favour of reviewing the EU’s Biopatent Directive.
Germany and the UK are in favour of reviewing the EU's Biopatent Directive. According to German Handelsblatt, German research minister Bulmahn has agreed with her UK colleague Lord Sainsbury that changes to the 1998 Directive are urgently needed to make sure that licencing issues do not impede innovation in this area.
The Directive 98/44/EC on the legal protection of biotechnological inventions was approved in 1998 after a decade of struggle over whether or not to legalise Patents on Life in Europe. The directive had already been challenged by the Dutch, Italian and Norwegian (as member of EEA) governments for its inconsistencies and for its lack of clarifying the legal situation.